Boston Scientific Sees Q2 Adj EPS $0.82-$0.84 vs $0.86 Est; Sees Sales $5.339B-$5.441B vs $5.553B Est

Benzinga Newsdesk www.benzinga.com Neutral 71.6%

Neg 0% Neu 71.6% Pos 0%

Boston Scientific (NYSE:BSX) is looking for Q2 Adj EPS of $0.82-$0.84 vs $0.86 analyst estimate. sees sales of $5.339 billion-$5.441 billion vs $5.553 billion analyst estimate.